Related Experiment Video
Updated: May 17, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease
Jelena Kotur-Stevuljević1, Amira Peco-Antić, Slavica Spasić
1Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, P. Box 146, 11000 Belgrade, Serbia. jkotur@pharmacy.bg.ac.rs
Insights
Children with chronic kidney disease (CKD) experience early atherosclerosis due to dyslipidemia and oxidative stress. Monitoring these factors and vessel wall changes is crucial for effective treatment strategies.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Research
- Biochemistry
Background:
- Investigated the roles of dyslipidemia and oxidative stress in early atherosclerosis among pediatric chronic kidney disease (CKD) patients.
- Utilized common carotid artery intima-media thickness (cIMT) as a biomarker for subclinical atherosclerosis.
Purpose of the Study:
- To evaluate the association between dyslipidemia, oxidative stress, and early atherosclerotic changes in children with CKD.
- To assess lipid and oxidative stress parameters in pediatric CKD patients undergoing different treatment modalities.
Main Methods:
- Enrolled 52 pediatric CKD patients (chronic renal failure, renal transplant, chronic hemodialysis) and 36 healthy controls.
- Assessed lipid profiles, oxidative stress markers (malondialdehyde), antioxidant status (superoxide dismutase), and paraoxonase 1 (PON1).
- Measured cIMT using ultrasound, adjusting for age and sex to obtain standard deviation scores (SDS).
Main Results:
- Pediatric CKD patients exhibited dyslipidemia, most significantly in chronic hemodialysis patients, with elevated free cholesterol and triglycerides.
- Markedly increased oxidative stress (higher malondialdehyde) and compromised antioxidant defense (lower superoxide dismutase) were observed in CKD groups compared to controls.
- Multiple regression analysis indicated that disease duration, blood pressure, urea, lipid, and oxidative status parameters explained over 90% of the variability in cIMT-SDS.
Conclusions:
- Dyslipidemia and oxidative stress contribute significantly to the pathogenesis of early atherosclerosis in children with CKD.
- Monitoring vascular changes, oxidative stress, and high-density lipoprotein (HDL) functionality is essential for developing improved therapeutic strategies to mitigate atherosclerotic progression.
Background:
The roles of dyslipidemia and oxidative stress in the early phases of atherosclerosis were tested in children with chronic kidney disease (CKD). Intima media thickness of common carotid arteries (cIMT) is used as a measure of early atherosclerosis.
Methods:
Fifty-two pediatric CKD patients were enrolled in the study (10 with chronic renal failure [CRF], 22 with a renal transplant [RT], 20 with chronic hemodialysis (cHD) patients, and 36 healthy children (control group, CG). Lipid status, oxidative stress, and paraoxonase 1 (PON1) status were assessed. cIMT was measured by ultrasound, adjusted for age and sex, and presented as standard deviation scores (SDS).
Results:
Children with CKD had disturbed lipid content, which was most pronounced in cHD children, with higher free cholesterol and triglycerides compared with healthy children. Oxidative stress was markedly increased (malodialdehyde [MDA, μmol/L]: CRF 1.50 ± 0.26, RT 1.55 ± 0.40, cHD 1.77 ± 0.34, CG 0.97 ± 0.33, p < 0.001) and antioxidative defense was compromised (superoxide dismutase [SOD, U/L]: CG 120 ± 21, CRF 84 ± 25, RT 93 ± 12, cHD 119 ± 37, p < 0.001). Multiple linear regression analysis showed that a model that included disease duration, blood pressure, urea, lipid, and oxidative status parameters accounted for more than 90% of the variability of cIMT-SDS.
Conclusions:
Early atherosclerosis in CKD children is caused, at least in part, by dyslipidemia and oxidative stress. Monitoring of vessel wall changes, along with assessment of oxidative stress status and high density lipoprotein (HDL) functionality is necessary to ensure better therapeutic strategies for delaying atherosclerotic changes in their asymptomatic phase.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
